Y, K., S, K., & M, S. (2020). Reduced Prescription of Baloxavir After Suspected Prevalence of a Baloxavir-Resistant Influenza Virus Strain and the Emergence of SARS-CoV-2 in a Tertiary Hospital in Japan. Dove Medical Press.
Cita Chicago Style (17a ed.)Y, Kamioka, Kashiwagura S, y Seki M. Reduced Prescription of Baloxavir After Suspected Prevalence of a Baloxavir-Resistant Influenza Virus Strain and the Emergence of SARS-CoV-2 in a Tertiary Hospital in Japan. Dove Medical Press, 2020.
Cita MLA (8a ed.)Y, Kamioka, et al. Reduced Prescription of Baloxavir After Suspected Prevalence of a Baloxavir-Resistant Influenza Virus Strain and the Emergence of SARS-CoV-2 in a Tertiary Hospital in Japan. Dove Medical Press, 2020.
Precaución: Estas citas no son 100% exactas.